Pricing reflects the starting medication cost
Study 4 was a 68-week trial that enrolled 611 patients with obesity (BMI greater than or equal to 30 kg/m2) or with overweight (BMI 27 to 29.9 kg/m2) and at least one weight-related comorbid condition such as treated or untreated dyslipidemia or hypertension
MT1 has demonstrated a longer half-life compared to native -MSH, making it a valuable research compound for studying sustained melanocortin receptor activity and its downstream physiological effects in controlled laboratory settings
These consist of symptoms of a serious allergic reaction, like difficulty breathing, swelling, or rash
Furthermore, the presence of a robust healthcare system, favorable reimbursement schemes, and leading pharmaceutical companies is expected to boost growth in the market
Dr Lim emphasised that semaglutide should be used alongside lifestyle and dietary changes, where these modifications alone often lead to minimal weight loss